Denise Scots-Knight

Insider Reports History

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., 60 Hampshire Street, Cambridge, MA
Signature
/s/ Christine Fox, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Denise Scots-Knight:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mereo BioPharma Group plc Chief Executive Officer, Director American Depositary Shares representing Ordinary Shares 809K $3.41M $4.22 Sep 13, 2024 Direct
Elanco Animal Health Inc Director Common Stock 60.2K $866K $14.37 Nov 30, 2023 Direct
Mereo BioPharma Group plc Chief Executive Officer, Director Share Options (Right to buy) 850K $859K $1.01 Jan 25, 2024 Direct
Mereo BioPharma Group plc Chief Executive Officer, Director Performance Based Restricted Stock Unit 0 Sep 11, 2024 Direct

Insider Reports Filed by Denise Scots-Knight

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MREO Mereo BioPharma Group plc Sep 12, 2024 2 -$381K 4 Sep 16, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Sep 11, 2024 2 $0 4 Sep 13, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Jun 25, 2024 2 -$463K 4 Jun 27, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Jun 21, 2024 2 $0 4 Jun 25, 2024 Chief Executive Officer, Director
MREO Mereo BioPharma Group plc Jan 25, 2024 1 $0 4 Jan 26, 2024 Chief Executive Officer
MREO Mereo Biopharma Group plc Jan 1, 2024 0 $0 3 Jan 2, 2024 Chief Executive Officer
ELAN Elanco Animal Health Inc Nov 30, 2023 1 $0 4 Dec 4, 2023 Director
ELAN Elanco Animal Health Inc Nov 30, 2022 1 $0 4 Dec 2, 2022 Director
ELAN Elanco Animal Health Inc Nov 30, 2021 1 $0 4 Dec 2, 2021 Director